Cyclophosphamide Versus Anti-thymocyte Globulin for GVHD Prophylaxis After RIC Allo-SCT
Clinical trial NCT02876679 · COMPLETED
Trial details
- NCT number
- NCT02876679
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-04-06
- Primary completion
- 2020-10-12
- Enrollment
- 94
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.